Cytek Biosciences, Inc. (CTKB) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of Cytek Biosciences, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTKB
Cytek Biosciences, Inc.
$5.56HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$7.99HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — CTKB vs OLMA
growth of $100 · dividends reinvested · last 5yCTKB -67.5% (-20.1%/yr)OLMA -68.0% (-20.4%/yr)CTKB compounded faster over this window
CTKB OLMA
CTKB vs OLMA: by the numbers
- •CTKB is the larger company ($719M vs $698M market cap).
- •Both run net losses; OLMA's is the smaller (0.00% vs -38.98% net margin).
Metrics side by side
Valuation
| Metric | CTKB | OLMA |
|---|---|---|
| P/S ratio | 3.48 | N/A |
| P/B ratio | 2.23 | 1.62 |
Profitability
| Metric | CTKB | OLMA |
|---|---|---|
| Gross margin | 53.23% | 0.00% |
| Operating margin | -21.60% | 0.00% |
| Net margin | -38.98% | 0.00% |
| ROE | -25.03% | -47.51% |
| ROIC | -12.00% | -50.92% |
Growth (annualized)
| Metric | CTKB | OLMA |
|---|---|---|
| Revenue CAGR (5Y) | 13.37% | N/A |
| Total return CAGR (5Y) | -23.16% | -21.50% |
Frequently asked
- How have CTKB and OLMA total returns compared?
- Over the past 5 years, CTKB delivered -23.16% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.